Research Coverage of Japanese Listed Companies, Shared Research Inc

Shared Research

Research Coverage of Japanese Listed Companies

Shared Research Inc

Pioneering research coverage of Japanese listed companies. Now customizable and interactive for global institutional investors. Corporate access reimagined.

Equity Bottom-Up

<ul><li>Q1 FY11/26 revenue was JPY7.6bn, a YoY decline of 8.6%, with operating profit at JPY401mn, down 49.8%.</li><li>Sales representatives totaled 2,265, a YoY decrease of 281, and newly acquired policies were 47,817, down 16.0%.</li><li>Policy transfer agreements reached 841, an 83.1% YoY decrease, despite increased inquiries due to potential regulatory changes.</li></ul>

Q1 FY11/26 revenue was JPY7.6bn, a YoY decline of 8.6%, with operating profit at JPY401mn, down 49.8%.Sales representatives totaled 2,265, a YoY decrease of 281, and newly acquired policies were 47,817, down 16.0%.Policy transfer agreements reached 841, an 83.1% YoY decrease, despite increased inquiries due to potential regulatory changes.

FP Partner (7388 JP): Q1 FY11/26 Flash update

<ul><li>In FY11/25, revenue was JPY32.1bn (-9.9% YoY), operating profit JPY3.0bn (-44.0% YoY), exceeding revised forecasts.</li><li>At end-FY11/25, sales representatives numbered 2,333 (-185 YoY), new policies acquired totaled 228,111 (-8.9% YoY).</li><li>FY11/26 forecasts revenue JPY36.3bn (+12.9% YoY), operating profit JPY3.3bn (+11.5% YoY), dividend per share JPY94.00.</li></ul>

In FY11/25, revenue was JPY32.1bn (-9.9% YoY), operating profit JPY3.0bn (-44.0% YoY), exceeding revised forecasts.At end-FY11/25, sales representatives numbered 2,333 (-185 YoY), new policies acquired totaled 228,111 (-8.9% YoY).FY11/26 forecasts revenue JPY36.3bn (+12.9% YoY), operating profit JPY3.3bn (+11.5% YoY), dividend per share JPY94.00.

FP Partner (7388 JP): Full-year FY11/25 flash update

<ul><li>Cumulative Q3 FY11/25 revenue was JPY24.4bn (-9.7% YoY), with operating profit at JPY2.2bn (-49.8% YoY). </li><li>Full-year forecast revised: revenue JPY32.0bn (-2.0%), operating profit JPY2.5bn (+19.8%), net income JPY1.7bn (+25.0%). </li><li>Dividend forecast unchanged at JPY94 per share, with a year-end dividend of JPY47 per share.</li></ul>

Cumulative Q3 FY11/25 revenue was JPY24.4bn (-9.7% YoY), with operating profit at JPY2.2bn (-49.8% YoY). Full-year forecast revised: revenue JPY32.0bn (-2.0%), operating profit JPY2.5bn (+19.8%), net income JPY1.7bn (+25.0%). Dividend forecast unchanged at JPY94 per share, with a year-end dividend of JPY47 per share.

FP Partner (7388 JP): Q3 FY11/25 flash update

<ul><li>In 1H FY11/25, revenue was JPY16.4bn (-4.1% YoY), with operating profit at JPY1.5bn (-45.0% YoY).</li><li>Full-year forecasts revised downward: revenue JPY32.6bn, operating profit JPY2.1bn, net income JPY1.3bn, EPS JPY58.20.</li><li>Dividend forecast remains unchanged at JPY94 per share, despite downward revision of full-year net income forecast.</li></ul>

In 1H FY11/25, revenue was JPY16.4bn (-4.1% YoY), with operating profit at JPY1.5bn (-45.0% YoY).Full-year forecasts revised downward: revenue JPY32.6bn, operating profit JPY2.1bn, net income JPY1.3bn, EPS JPY58.20.Dividend forecast remains unchanged at JPY94 per share, despite downward revision of full-year net income forecast.

FP Partner (7388 JP): 1H FY11/25 flash update

Asia Pac ECM and Index Rebal, DZT Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Quantitative Analysis

<ul>
<li>We analyzed the changes in margin trading positions of JPX stocks as of Apr 10th. The aggregated net margin trading position is USD21,502m.</li>
<li>We tabulate league tables for top/bottom net long/short of margin trading by value, net margin buy as multiple of ADT.</li>
<li>We highlight net margin buy/sell changes in Advantest, Kioxia, Lasertec, Fast Retailing, Fujikura, Nintendo, Tokyo Electron, JX Advanced Metals, Mitsubishi Heavy Industries, SoftBank.</li>
</ul>


We analyzed the changes in margin trading positions of JPX stocks as of Apr 10th. The aggregated net margin trading position is USD21,502m.
We tabulate league tables for top/bottom net long/short of margin trading by value, net margin buy as multiple of ADT.
We highlight net margin buy/sell changes in Advantest, Kioxia, Lasertec, Fast Retailing, Fujikura, Nintendo, Tokyo Electron, JX Advanced Metals, Mitsubishi Heavy Industries, SoftBank.


JPX Margin Trading Weekly (Apr 10th): Advantest, Kioxia, Lasertec, Fast Retailing, Fujikura

Japan

FP Partner Inc. offers financial services. The Company provides financial planning, insurance marketing and consulting, insurance agency, and other services. FP Partner also offers consultation site operation.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

FP Partner (7388 JP)